3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
6
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Breast Cancer
2
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Anxiety Disorders
1
Amyotrophic Lateral Sclerosis
1
Interventions
Carboplatin
3
zipalertinib
2
Cisplatin
2
zimberelimab
1
sacituzumab govitecan
1
repotrectinib
1
pembrolizumab
1
durvalumab
1
alectinib
1
Pemetrexed
1
One-Lung Ventilation
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Diseases
×
Injections
×
30 days
×
Clear all
No trials found.